FASENRA PEN

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: d45d3f987b183154
Drug Approval Canada Name: FASENRA PEN
Product Name: FASENRA PEN
Status: Marketed
Status Date: 2021-01-13
Original Market Date: 2021-01-13
Din: 02496135
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 48:10.20
Atc Original: R03DX10 BENRALIZUMAB
Atc Name: r 03 dx 10
Aig Number: 0159970001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

BENRALIZUMAB

30 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d45d3f987b183154

Type

Standard